¨¾¬Ì¤£§Ñ¼W±j§K¬Ì¤O¡I Àç¾i®vµ¹¿Ë¤lªº7­Ó¶¼­¹¤p§Þ¥©

2021-06-15 2066

¥@¬É½Ã¥Í²Õ´WHO«Øij¡A¦b·s«aªÍª¢¬Ì±¡´Á¶¡¡A¨C­Ó®a®x»Ý­n«ùÄò°·±d¶¼­¹¤Î³W«ß¹B°Êªº¥Í¬¡«¬ºA¡A±dÁp¥ÍÂåÅé­«ºÞ²z¤¤¤ßÀç¾i±M®a©xÑ{´£¨Ñ¥H¤U7­Ó¤p§Þ¥©¡A®aªø¤£§«©M«Ä¤l¤@°_³z¹L¶¼­¹©M¹B°Ê°·±d¦¨ªø¡A¼W±j°·±d§K¬Ì¤O§a¡I

·s«aªÍª¢¡]COVID-19¡^©µ¿N¥xÆWªÀ°Ï¡A¥þ°ê¶i¤J3¯Åĵ§Ù¡A¤£¤Ö¤½¥q§ï±Ä©~®a¿ì¤½¡A¥þ°ê¦U¯Å¾Ç®Õ¤Î¤½¨p¥ß¥®¨à¶é«h«Å¥¬°±¤î¨ì®Õ¤W½Ò©µªø¡A´î¤Ö¸s»E¡F¥»¤g¬Ì±¡ÄY®m¡A¥Á²³³£§V¤O¦b®a¨¾¬Ì¨Ã´Á¬ß¯à»°§Ö±µ¨ü¬Ì­]¬I¥´¡AµM¦Ó¡A¤]¦³®aªøºÃ´b¡A¥xÆW¨àµ£¡B«C¤Ö¦~·|¦³·s«a¬Ì­]¥i¥´¶Ü¡H

±dÁp¥ÍÂåÅé­«ºÞ²z¤¤¤ßÀç¾i±M®a©xÑ{ªí¥Ü¡A®Ú¾Ú½ÃºÖ³¡¯eºÞ¸p6¤ëªì¤½§i·s«a¬Ì­]¥é³æªº¾A¥Î±µºØ¦~ÄÖ¡A­^°êªü´µ¯S±¶§Q±d¡]AstraZeneca¡FAZ¡^¤Î¬ü°ê²ö¼w¯Ç¡]Moderna¡^¬Ì­]¾A¥Î©ó18·³¥H¤W¡A¬ü°ê½÷·ç(Pfizer)Ãļt»P¼w°ê¥Í§Þ¤½¥qBioNTechÁp¦X¬ãµoªº·s«a¬Ì­]«h¾A¥Î©ó16·³¥H¤W¡A¥t¨Ì¾Ú°ê»ÚÁͶաA½÷·çBNT¬Ì­]¤w¨ü¨ì³¡¤À°ê®a§å­ã¥i±µºØ©ó12~15·³ªº«C¤Ö¦~¡A¥]¬A¥[®³¤j½Ã¥Í¸p¡]Health Canada¡^¡B¬ü°ê­¹«~ÃĪ«ºÞ²z§½¡]FDA¡^¡B¼Ú·ùÃÄ«~ºÞ²z§½¡]EMA¡^¦Û¤µ¦~¤­¤ë°_³°Äò¤½§i®Ö­ã¡A¦ý¡A°ê»Ú¶¡¨ÌµM¨S¦³¾A¦X12·³¥H¤U¨àµ£ªº·s«a¬Ì­]¡C

¨º»ò¨¾¬Ì´Á¶¡¡A®aªø¦p¦óÅý¥xÆW¨àµ£­ÝÅUÀç¾i§¡¿Å¡A¥[±j§K¬Ì¤O©è¿m¯f¬r«Iŧ©O¡H¥@¬É½Ã¥Í²Õ´WHO«Øij¡A¦b·s«aªÍª¢¬Ì±¡´Á¶¡¡A¨C­Ó®a®x»Ý­n«ùÄò°·±d¶¼­¹¤Î³W«ß¹B°Êªº¥Í¬¡«¬ºA¡A±dÁp¥ÍÂåÅé­«ºÞ²z¤¤¤ßÀç¾i±M®a©xÑ{´£¨Ñ¥H¤U7­Ó¤p§Þ¥©¡A®aªø¤£§«©M«Ä¤l¤@°_³z¹L¶¼­¹©M¹B°Ê°·±d¦¨ªø¡A¼W±j°·±d§K¬Ì¤O§a¡I

▸§Þ¥©1¡G§¡¿Å6¤jÃþ¶¼­¹ Àç¾i®v«Øij³o¼Ë¦Y

¨àµ£¥Íªøµo¨|ªº¶¥¬q¡A§¡¿Åªº¶¼­¹¤×¨ä­«­n¡A¨C¤Ñ³£À³¸Ó§¡¿ÅÄá¨ú6¤jÃþ­¹ª«¡A¥]¬A¥þâBÂø³Ãþ¡B½­µæÃþ¡B¤ôªGÃþ¡B¨§³½³J¦×Ãþ¡B¨Å«~Ãþ¡A¥H¤Îªo¯×»P°íªGºØ¤lÃþ¡AÅý¨­Åé¦U³¡¦ì³£¯à°·±dªº¥Íªø»Pµo®i¡C¶t½è¤ÎÀu½è³J¥Õ½è¬O¥Íªøµo¨|¤£¥i©Î¯Êªº­ì®Æ¡A¨C¤ÑÀ³Äá¨ú1.5¦Ü2ªMªº¨Å«~Ãþ¡A±j¤Æ°©Àfªº¥Íªø¡A¨ÃÄá¨ú³J¡B³½¡B¦×¤Î¨§»Gµ¥Àu½èªº³J¥Õ½è¡AÅý¨­Åé²Õ´°·±d¦a«Øºc¦¨ªø¡AWHO¨Ã«Øij¨àµ£¨C©P¿¯­¹¦Ü¤Ö¦³2¦¸Äá¨ú³½Ãþ¡A¨ä¤¤¦Ü¤Ö¦³1¦¸¬O§t°ªªo¯×³½Ãþ¡]¦pÂD³½¡B¨F¤B³½¡BÄJ³½¡BøW³½µ¥¡^¡C

▸§Þ¥©2¡G¸É¥RÀç¾i¯À ¦Y¥X¦n§K¬Ì

®Ú¾Ú¬ü°ê¯e¯fºÞ¨î§½¡]CDC¡^«Øij¡Aºû¥Í¯ÀC¡BD¤Î¾N¹ï©ó´£¤É§K¬Ì¤O©è§Ü·P¬V¡Bµoª¢¤Î¬õ¸~¥i¯à¦³À°§U¡A°£¤F±q¤ÑµMªº­¹ª«¸É¥R¡]¦Y½­ªG¸É¥Rºû¥Í¯ÀC¡A³Ü¤û¥¤¸É¥Rºû¥Í¯ÀD¡A¦Y½G¦×¤Î®üÂAµ¥¸É¥R¾N¡^¡A¤]¯à¾A®É¾A¶q¦a¸É¥R«O°·­¹«~¡F¥t¥~¡AÄá¨ú¨¬°÷ªºÅK¡Bºû¥Í¯ÀA¡Bºû¥Í¯ÀB12¡BB6¤Îºû¥Í¯ÀE¤]¦³§U©óºû«ù§K¬Ì¨t²Îªº¥\¯à¡C

▸§Þ¥©3¡G¿¯­¹­«½è¤S­«¶q ¼W±j¨¾¿m¤O

¨¾¬Ì´Á¶¡§ó­nª`­«¼W±j¨¾¿m¤Oªº¶¼­¹¡A¦Y¦hºØÃC¦âªº½­ªG¯àÀò±o¦UºØºû¥Í¯À¡BÄqª«½è¤Î´Ó¤Æ¯À¡A¤×¨ä¬O²`ºñ¦â¸­µæÃþ¤Î¾ï¶À¦âªº½­ªG¹ï¼W±j§K¬Ì¨t²Î§ó¦³À°§U¡F¥H°ªÅÖªº¥þâBÂø³Ãþ¨ú¥Nºë»s¾ý¯»Ãþ¡A¼W¥[¿¯­¹ÅÖºûÄá¨ú¶q¡A¦³§U©ó´£¤É¸z¹D¥\¯à¶i¦Ó±j¤Æ§K¬Ì¤O¡F¦h¿ï¾Ü¯×ªÕ§t¶q¸û§Cªº¦×Ãþ¡A¨Ã¦Y¨¬¨C¤é©Ò»Ýªº³J¥Õ½è¶q¡AÅý¨­Å馳¨¬°÷ªº§÷®Æ»s³y§K¬Ì²Ó­M¡C

▸§Þ¥©4¡G´î¤Ö§t°ªªo¡B°ªÆQ¡B°ª¿} ¹L«×¥[¤uªº­¹«~¤]­n»·Â÷

°ê¥~¦³¬ã¨sÅã¥Ü¡Aªø´Á©~®a¥Í¬¡®e©ö¦Y¶i¹L¦h°ª¼ö¶qªº¥[¤u­¹«~¡A¤£¦ý·|³y¦¨¨àµ£Åé­«¼W¥[¡A¨ä¤¤ºë»s¿}¡B¤Ï¦¡¯×ªÕ¤Î¥[¤u¦×Ãþµ¥­¹«~®e©ö¤Þµo¨­Åéµoª¢¤ÏÀ³¡A¾É­P§K¬Ì¤O¤U­°¡C

▸§Þ¥©5¡G¨C¤é¦Ü¤Ö³Ü1,500ml¥Õ¶}¤ô ½Õ¸`¨­Åé«OÅ@¤O

¨­Åé²Õ¦¨¦³70%¬O¤ô¡A³Ü¥Õ¶}¤ô¦³§U©ó¨­Å鶶§Q¥NÁ¡A±Æ°£¼oª«²b¤ÆÅé½è¡A°ê¤p¾Çµ£¨C¤é¦Ü¤Ö¶·1,500ml¤ô¡A¤À¦¸¤p¤fºC¶¼¡A¾i¦¨¦n²ßºD³Ü¶}¤ô¥H¨ú¥N§t¿}¶¼®Æ¡AÁקK³Ü¶i¹L¦hªº¿}¤À¤Î¼ö¶q¡A¤~¯à½Õ¸`«OÅ@¤O¡C

▸§Þ¥©6¡G¿Ë¤l¦P°µ®Æ²z ¼W¥[°·±d­¹§÷³ß·R«×

¬Ì±¡´Á¶¡¦b®a¤]¥i¥H»P«Ä¤l¤@°_°Ê¤â¤U¼p¡A¥Î·sÂAªº­¹§÷»s§@²©ö¤S¬ü¨ýªº®Æ²z¡A¡u¦Û¤v°µªºªF¦è³Ì¦n¦Y¡v¡AÅý«Ä¤l±qÀ\ÂI¦¨«~Àò±o¦¨´N·P¡A¨Ã¼W¥[¹ï°·±d­¹§÷ªº±µ¨ü«×»P³ß·R«×¡C

▸§Þ¥©7¡G¦­ºÎ¤SºÎ¹¡ ªø°ªÅܱj¨­

ºÎ¯v¤£¨¬¥i¯à·|¾É­PÅ餺²üº¸»X¤£¥­¿Å¡A´N·|¼W¥[¶i­¹ªº¾÷·|¡A¤]®e©ö¼vÅT¨ì¨­Å骺§K¬Ì¤O¡C¥R¨¬ªººÎ¯v¯à¼W¥[¥Íªø¿E¯Àªº¤Àªc¡A¹ï«Ä¤lªø°ª¦³À°§U¡A¤]Åý«Ä¤lªººë¯«¸û¦n¡AºÎ¯v®É¶¡¥R¨¬¤ÎºÎ¯v«~½è¨Î³£¦³§U©ó´£¤É«Ä¤l¤é±`¥Í¬¡¤Î¾Ç²ß¯à¤Oªºªí²{¡C

¨¾¬Ì´Á¶¡§Q¥Î©~®a¥Í¬¡ªº¾÷·|³­¦ñ«Ä¤l¾i¦¨°·±d¥Í¬¡«¬ºA¡A³z¹L§¡¿Å¤SÀç¾iªº¶¼­¹·f°t¾A«×ªº¬¡°Ê¶q¼W±j§K¬Ì¤O¡A¨ÃµÎ½w©~®a¨¾¬Ì´Á¶¡ªºÀ£¤O¡AÅý«Ä¤l§Ö¼Ö°·±d¦a¾Ç²ß¦¨ªø¡A¤@¦P«×¹L³o¦¸ªº¬Ì±¡¡C¡]¤ý¸ÖÓ}¡þ·s¥_³ø¾É¡^

¨Ó·½¡G¨¾¬Ì¤£§Ñ¼W±j§K¬Ì¤O¡I Àç¾i®vµ¹¿Ë¤lªº7­Ó¶¼­¹¤p§Þ¥©
¥X³B¡GNOW°·±d

ment,'script','//www.google-analytics.com/analytics.js','ga'); ga('create', 'UA-35937129-1', 'auto'); ga('send', 'pageview');